X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hema23 (8) 8
humans (8) 8
index medicus (8) 8
oncology (8) 8
female (6) 6
male (6) 6
aged (5) 5
middle aged (5) 5
original reports (5) 5
adult (4) 4
antineoplastic agents - therapeutic use (4) 4
multiple myeloma - drug therapy (4) 4
treatment outcome (4) 4
aged, 80 and over (3) 3
bortezomib (3) 3
disease-free survival (3) 3
hema21 (3) 3
hema25 (3) 3
hema7 (3) 3
phase-ii (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
boronic acids - administration & dosage (2) 2
boronic acids - adverse effects (2) 2
chronic myelogenous leukemia (2) 2
follow-up (2) 2
hema15 (2) 2
hema20 (2) 2
hema22 (2) 2
hema24 (2) 2
imatinib mesylate (2) 2
interferon (2) 2
kaplan-meier estimate (2) 2
molecular responses (2) 2
monoclonal gammopathy (2) 2
plus dexamethasone (2) 2
pyrazines - administration & dosage (2) 2
pyrazines - adverse effects (2) 2
pyrimidines - therapeutic use (2) 2
stem-cell transplantation (2) 2
young adult (2) 2
2nd international workshop (1) 1
administration, intravenous (1) 1
adolescent (1) 1
advanced thyroid-cancer (1) 1
alpha plus cytarabine (1) 1
amn107 (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, murine-derived (1) 1
apex trial (1) 1
asco special (1) 1
asco special articles (1) 1
bc3 (1) 1
bc4 (1) 1
bc5 (1) 1
bc6 (1) 1
bcr-abl (1) 1
benzamides (1) 1
bios3 (1) 1
blood viscosity - drug effects (1) 1
bone density conservation agents - administration & dosage (1) 1
bone density conservation agents - therapeutic use (1) 1
bone diseases - complications (1) 1
bone diseases - drug therapy (1) 1
bone diseases - radiotherapy (1) 1
bone marrow neoplasms - drug therapy (1) 1
bone marrow neoplasms - secondary (1) 1
bone1 (1) 1
bone2 (1) 1
bone5 (1) 1
boronic acids - therapeutic use (1) 1
breast neoplasms - therapy (1) 1
central nervous system neoplasms - therapy (1) 1
child (1) 1
chop-r (1) 1
clinic consensus statement (1) 1
clodronic acid - administration & dosage (1) 1
clodronic acid - therapeutic use (1) 1
clonal evolution - drug effects (1) 1
combined modality therapy (1) 1
consensus panel recommendations (1) 1
cooperative-oncology-group (1) 1
cytarabine (1) 1
cytogenetic responses (1) 1
dasatinib (1) 1
dexamethasone - administration & dosage (1) 1
dexamethasone - adverse effects (1) 1
diphosphonates - administration & dosage (1) 1
diphosphonates - therapeutic use (1) 1
disease progression (1) 1
double-blind (1) 1
drug administration schedule (1) 1
drug resistance, neoplasm (1) 1
drug synergism (1) 1
drug therapy, combination (1) 1
dxst (1) 1
dxst1 (1) 1
dxst2 (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 01/2010, Volume 28, Issue 3, pp. 392 - 397
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2013, Volume 31, Issue 18, pp. 2347 - 2357
Purpose The aim of the International Myeloma Working Group was to develop practice recommendations for the management of multiple myeloma (MM) -related bone... 
ZOLEDRONIC ACID | ONCOLOGY | VERTEBRAL AUGMENTATION | SKELETAL-RELATED EVENTS | UNDETERMINED SIGNIFICANCE | DOUBLE-BLIND | MONOCLONAL GAMMOPATHY | RANDOMIZED CONTROLLED-TRIAL | CLINIC CONSENSUS STATEMENT | SPINAL-CORD COMPRESSION | VITAMIN-D DEFICIENCY | Outcome Assessment (Health Care) - methods | Humans | Imidazoles - administration & dosage | Tomography, X-Ray Computed | Positron-Emission Tomography | Fractures, Bone - diagnosis | Medical Oncology - organization & administration | Multiple Myeloma - drug therapy | Bone Diseases - drug therapy | Diphosphonates - therapeutic use | Imidazoles - therapeutic use | Drug Therapy, Combination | Osteonecrosis - diagnosis | Bone Diseases - complications | Multiple Myeloma - complications | Bone Density Conservation Agents - therapeutic use | Bone Diseases - radiotherapy | Combined Modality Therapy | Diphosphonates - administration & dosage | International Cooperation | Bone Density Conservation Agents - administration & dosage | Magnetic Resonance Imaging | Administration, Intravenous | Radiotherapy - methods | Clodronic Acid - therapeutic use | Clodronic Acid - administration & dosage | Multiple Myeloma - radiotherapy | Osteonecrosis - prevention & control | Fractures, Bone - prevention & control | Practice Guidelines as Topic | Index Medicus | Hema20 | Gdln2 | Bone5 | Special | Hema23 | Hema22 | Hema21
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2009, Volume 27, Issue 21, pp. 3518 - 3525
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2009, Volume 27, Issue 23, pp. 3830 - 3835
Purpose We examined the activity of bortezomib, dexamethasone, and rituximab (BDR) in patients with symptomatic, untreated Waldenstrom macroglobulinemia (WM).... 
CONSENSUS PANEL RECOMMENDATIONS | 2ND INTERNATIONAL WORKSHOP | MANTLE-CELL LYMPHOMA | IN-VITRO | ONCOLOGY | PROTEASOME INHIBITOR BORTEZOMIB | NON-HODGKINS-LYMPHOMA | PHASE-II | RELAPSED MULTIPLE-MYELOMA | CHOP-R | COOPERATIVE-ONCOLOGY-GROUP | Herpes Zoster - prevention & control | Humans | Middle Aged | Pyrazines - administration & dosage | Antibodies, Monoclonal - adverse effects | Hematocrit | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Boronic Acids - adverse effects | Dexamethasone - adverse effects | Male | Waldenstrom Macroglobulinemia - pathology | Waldenstrom Macroglobulinemia - drug therapy | Aged, 80 and over | Female | Boronic Acids - administration & dosage | Waldenstrom Macroglobulinemia - blood | Antibodies, Monoclonal, Murine-Derived | Bortezomib | Dexamethasone - administration & dosage | Drug Administration Schedule | Blood Viscosity - drug effects | Kaplan-Meier Estimate | Rituximab | Treatment Outcome | Bone Marrow Neoplasms - secondary | Herpes Zoster - chemically induced | Disease-Free Survival | Immunoglobulin M - blood | Platelet Count | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrazines - adverse effects | Aged | Bone Marrow Neoplasms - drug therapy | Index Medicus | Original Reports | Hema15 | Bios3 | Hema23
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2009, Volume 27, Issue 5, pp. 812 - 826
Nearly 40 years ago, President Richard Nixon signed the National Cancer Act, mobilizing the country's resources to make the "conquest of cancer a national... 
TRIAL | STAGE BREAST-CANCER | WOMEN | MELANOMA | ONCOLOGY | ADVANCED THYROID-CANCER | PROSTATE-CANCER | LETROZOLE | PHASE-II | FINASTERIDE | SORAFENIB | United States | Humans | Central Nervous System Neoplasms - therapy | Male | Lung Neoplasms - therapy | Gastrointestinal Neoplasms - therapy | Research | Sarcoma - therapy | Breast Neoplasms - therapy | Urogenital Neoplasms - therapy | Genital Neoplasms, Female - therapy | Medical Oncology - trends | Financing, Government - trends | Female | Child | Bone2 | Bone1 | To19 | To18 | To17 | Asco Special | To16 | Dxst | To25 | To24 | To23 | To22 | To21 | To20 | Sarc8 | Sarc7 | Dxst3 | Hsr1 | Sarc6 | Hsr2 | Sarc5 | Dxst1 | Sarc4 | Dxst2 | Thor3 | Thor4 | Thor5 | Thor6 | Psc14 | Psc13 | Thor7 | Thor8 | Thor9 | Neur6 | Neur4 | Neur5 | Neur3 | Gic20 | Pedi2 | Pedi3 | Gic2 | Gic19 | Gic18 | Gic4 | Gic3 | Thor11 | Gic6 | Gic5 | Gic11 | Gic9 | Gic10 | Gic13 | Gic12 | Guc3 | Guc4 | Gic17 | Gic16 | Guc2 | Gync10 | Gync11 | Gic31 | Gic30 | Gync16 | Gync17 | Gync18 | Gync19 | Gync12 | Sarc14 | Gync13 | Sarc15 | Sarc12 | Sarc13 | Pedi10 | Gic24 | Gic23 | Gic26 | Gic25 | Gic27 | Hema7 | Gync20 | Hema8 | Hema5 | Hema6 | Gic40 | Gdln1 | Hema19 | Hema15 | Hema14 | Hema13 | Hema12 | Hema11 | Gic33 | To15 | Gic32 | To14 | Gic34 | Gic37 | Gic39 | Gic38 | Guc5 | Guc6 | Guc18 | Guc17 | Guc16 | Guc9 | Guc13 | Guc12 | Guc11 | Gync2 | Guc10 | Gync4 | Hema24 | Gync3 | Hema23 | Gync6 | Hema22 | Gync5 | Hema21 | Hema20 | Bc4 | Bc3 | Gync9 | Bc6 | Hnc3 | Hnc12 | Bc5 | Hnc4 | Hnc13 | Hnc10 | Hnc2 | Hnc11 | Hnc5 | Hnc6 | Hnc9
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.